1. Home
  2. CYCC vs CSTE Comparison

CYCC vs CSTE Comparison

Compare CYCC & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • CSTE
  • Stock Information
  • Founded
  • CYCC 1992
  • CSTE 1987
  • Country
  • CYCC Malaysia
  • CSTE Israel
  • Employees
  • CYCC N/A
  • CSTE N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • CSTE Building Materials
  • Sector
  • CYCC Health Care
  • CSTE Industrials
  • Exchange
  • CYCC Nasdaq
  • CSTE Nasdaq
  • Market Cap
  • CYCC 61.2M
  • CSTE 62.2M
  • IPO Year
  • CYCC N/A
  • CSTE 2012
  • Fundamental
  • Price
  • CYCC $0.35
  • CSTE $2.00
  • Analyst Decision
  • CYCC
  • CSTE Strong Buy
  • Analyst Count
  • CYCC 0
  • CSTE 1
  • Target Price
  • CYCC N/A
  • CSTE $6.00
  • AVG Volume (30 Days)
  • CYCC 3.6M
  • CSTE 180.9K
  • Earning Date
  • CYCC 08-13-2025
  • CSTE 08-06-2025
  • Dividend Yield
  • CYCC 41.68%
  • CSTE N/A
  • EPS Growth
  • CYCC N/A
  • CSTE N/A
  • EPS
  • CYCC N/A
  • CSTE N/A
  • Revenue
  • CYCC $14,000.00
  • CSTE $424,487,000.00
  • Revenue This Year
  • CYCC $137.21
  • CSTE N/A
  • Revenue Next Year
  • CYCC N/A
  • CSTE $6.60
  • P/E Ratio
  • CYCC N/A
  • CSTE N/A
  • Revenue Growth
  • CYCC N/A
  • CSTE N/A
  • 52 Week Low
  • CYCC $0.25
  • CSTE $1.62
  • 52 Week High
  • CYCC $39.84
  • CSTE $6.54
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 25.10
  • CSTE 55.59
  • Support Level
  • CYCC $0.29
  • CSTE $1.62
  • Resistance Level
  • CYCC $0.46
  • CSTE $1.93
  • Average True Range (ATR)
  • CYCC 0.19
  • CSTE 0.14
  • MACD
  • CYCC 0.05
  • CSTE 0.06
  • Stochastic Oscillator
  • CYCC 6.33
  • CSTE 100.00

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: